H.R. 5432 — Introduced in House

I 117th CONGRESS 1st Session H. R. 5432 IN THE HOUSE OF REPRESENTATIVES September 30, 2021Mrs. Miller-Meeks introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To amend the Families First Coronavirus Response Act to require group health plans and health insurance issuers to cover T cell immune response testing without the imposition of cost sharing. 1. Short title This Act may be cited as the COVID–19 Testing Coverage Act of 2021. 2. Requiring group health plans and health insurance issuers to cover T cell immune response testing without the imposition of cost sharing Section 6001(a) of the Families First Coronavirus Response Act (42 U.S.C. 1320b–5 note) is amended— (1) in the matter preceding paragraph (1), by inserting (or, in the case of tests described in paragraph (3), beginning on or after the date of the enactment of such paragraph) after the date of the enactment of this Act; and (2) by adding at the end the following new paragraph: (3) Tests furnished to assess the T cell immune response of an individual to COVID–19. .